Bill Nye is on a mission to change the world — one voicemail at a time. Bill and science writer Corey S. Powell take your burning questions and put them to the world's leading experts on just about every topic in the universe. Should you stop eating cheeseburgers to combat climate change? Could alien life be swimming inside the moons of Jupiter and Saturn? Does your pet parakeet learn to sing the way that you learned to speak? Bill, Corey, and their special guests will answer those questions ...
…
continue reading
David G. Warnock, MD - The Future Looks Bright for People With Fabry Disease: Improving Diagnosis and Expanding Treatment Options
MP3•Bölüm sayfası
Manage episode 350229287 series 9881
İçerik PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Go online to PeerView.com/ZTU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert will review the pathophysiology and clinical heterogeneity of Fabry disease. With an emphasis on accurate, early diagnosis and timely treatment, the activity will test learners’ knowledge about current and emerging therapeutic options for patients with Fabry disease. Upon completion of this activity, participants should be better able to: Recognize the pathophysiology, signs and symptoms, clinical manifestations, and consequences of FD; Apply evidence-based tools, technologies, and strategies to diagnose individuals with FD in a timely manner; and Integrate current and emerging options into the treatment regimens, as appropriate, for patients with FD, taking into account the latest efficacy and safety data from recent clinical trials.
…
continue reading
85 bölüm